SERT Ileu425Val in autism, Asperger syndrome and obsessive-compulsive disorder

Psychiatric Genetics

Volumn 18, Issue 1, 2008, Pages 31-39

  Wendland, Jens R ^a   DeGuzman, Theresa B ^a   McMahon, Francis ^a   Rudnick, Gary ^b   Detera Wadleigh, Sevilla D ^a   Murphy, Dennis L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Genetics; Obsessive compulsive disorder; Serotonin

Indexed keywords

SEROTONIN TRANSPORTER;

ADULT; ARTICLE; ASPERGER SYNDROME; AUTISM; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FISHER EXACT TEST; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; POPULATION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ASPERGER SYNDROME; AUTISTIC DISORDER; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; HUMANS; ISOLEUCINE; MALE; MOLECULAR SEQUENCE DATA; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; VALINE;

EID: 38149093415     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3282f08a06     Document Type: Article

References (76)

1. Ahmadian A, Gharizadeh B, Gustafsson AC, Sterky F, Nyren P, Uhlen M, Lundeberg J (2000). Single-nucleotide polymorphism analysis by pyrosequencing. Anal Biochem 280:103-110.
2. Altemus M, Swedo SE, Leonard HL, Richter D, Rubinow DR, Potter WZ, Rapoport JL (1994). Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. Arch Gen Psychiatry 51:794-803.
3. Altemus M, Murphy DL, Greenberg B, Lesch KP (1996). Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder. Am J Med Genet 67:409-411.
4. Arnold PD, Siegel-Bartelt J, Cytrynbaum C, Teshima I, Schachar R (2001). Velocardio-facial syndrome: Implications of microdeletion 22q11 for schizophrenia and mood disorders. Am J Med Genet 105:354-362.
5. Bejerot S, Nylander L, Lindstrom E (2001). Autistic traits in obsessive-compulsive disorder. Nord J Psychiatry 55:169-176.
6. Bengel D, Greenberg BD, Cora-Locatelli G, Altemus M, Heils A, Li Q, Murphy DL (1999). Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol Psychiatry 4: 463-466.
7. Bolton PF, Pickles A, Murphy M, Rutter M (1998). Autism, affective and other psychiatric disorders: patterns of familial aggregation. Psychol Med 28: 385-395.
8. Buxbaum JD, Silverman J, Keddache M, Smith CJ, Hollander E, Ramoz N, Reichert JG (2004). Linkage analysis for autism in a subset families with obsessive-compulsive behaviors: evidence for an autism susceptibility gene on chromosome 1 and further support for susceptibility genes on chromosome 6 and 19. Mol Psychiatry 9:144-150.
9. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389.
10. Cavallini MC, Di Bella D, Pasquale L, Henin M, Bellodi L (1998). 5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder. Psychiatry Res 77:97-104.
11. Chabane N, Millet B, Delorme R, Lichtermann D, Mathieu F, Laplanche JL, et al. (2004). Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans. Neurosci Lett 363:154-156.
12. Conroy J, Meally E, Kearney G, Fitzgerald M, Gill M, Gallagher L (2004). Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Mol Psychiatry 9:587-593.
13. Cromer KR, Schmidt NB, Murphy DL (2007). An investigation of traumatic life events and obsessive-compulsive disorder. Behav Res Ther 45:1683-1691.
14. Delorme R, Betancur C, Wagner M, Krebs MO, Gorwood P, Pearl P, et al. (2005). Support for the association between the rare functional variant I425V of the serotonin transporter gene and susceptibility to obsessive compulsive disorder. Mol Psychiatry 10:1059-1061.
15. Do Rosario-Campos MC, Leckman JF, Curi M, Quatrano S, Katsovitch L, Miguel EC, et al. (2005). A family study of early-onset obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 136:92-97.
16. Enoch MA, Greenberg BD, Murphy DL, Goldman D (2001). Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder. Biol Psychiatry 49:385-388.
17. Fakhrai-Rad H, Pourmand N, Ronaghi M (2002). Pyrosequencing: an accurate detection platform for single nucleotide polymorphisms. Hum Mutat 19:479-485.
18. Glatt CE, Deyoung JA, Delgado S, Service SK, Giacomini KM, Edwards RH, et al. (2001). Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nat Genet 27:435-438.
19. Grados MA (2003). Obsessive-compulsive disorder after traumatic brain injury. Int Rev Psychiatry 15:350-358.
20. Greenberg BD, Benjamin J, Martin JD, Keuler D, Huang SJ, Altemus M, Murphy DL (1998). Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients. Psychopharmacology (Berl) 140:434-444.
21. Halmi KA, Sunday SR, Klump KL, Strober M, Leckman JF, Fichter M, et al. (2003). Obsessions and compulsions in anorexia nervosa subtypes. Int J Eat Disord 33:308-319.
22. Hanna GL, Veenstra-Vanderweele J, Cox NJ, Boehnke M, Himle JA, Curtis GC, et al. (2002). Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet 114:541-552.
23. Hasler G, Lasalle-Ricci VH, Ronquillo JG, Crawley SA, Cochran LW, Kazuba D, et al. (2005). Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity. Psychiatry Res 135:121-132.
24. Hemmings SM, Stein DJ (2006). The current status of association studies in obsessive-compulsive disorder. Psychiatr Clin North Am 29:411-444.
25. Hemmings SM, Kinnear CJ, Niehaus DJ, Moolman-Smook JC, Lochner C, Knowles JA, et al. (2003). Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder. Eur Neuropsychopharmacol 13:93-98.
26. Hollander E, King A, Delaney K, Smith CJ, Silverman JM (2003). Obsessive-compulsive behaviors in parents of multiplex autism families. Psychiatry Res 117:11-16.
27. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA (2005). An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 29:8-16.
28. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, et al. (2006). Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815-826.
29. IMGSAC (1998). A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum Mol Genet 7:571-578.
30. Insel TR, Mueller EA, Alterman I, Linnoila M, Murphy DL (1985). Obsessive-compulsive disorder and serotonin: is there a connection? Biol Psychiatry 20:1174-1188.
31. Jonnal AH, Gardner CO, Prescott CA, Kendler KS (2000). Obsessive and compulsive symptoms in a general population sample of female twins. Am J Med Genet 96:791-796.
32. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, Gogos JA (1997). Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94:4572-4575.
33. Kaye WH, Bulik CM, Thornton L, Barbarich N, Masters K (2004). Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry 161:2215-2221.
34. Kilic F, Murphy DL, Rudnick G (2003). A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol 64:440-446.
35. Kraft JB, Slager SL, Mcgrath PJ, Hamilton SP (2005). Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry 58:374-381.
36. LaSalle VH, Cromer KR, Nelson KN, Kazuba D, Justement L, Murphy DL (2004). Diagnostic interview assessed neuropsychiatric disorder comorbidity in 334 individuals with obsessive-compulsive disorder. Depress Anxiety 19: 163-173.
37. Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
38. Liu J, Nyholt DR, Magnussen P, Parano E, Pavone P, Geschwind D, et al. (2001). A genomewide screen for autism susceptibility loci. Am J Hum Genet 69:327-340.
39. Matsunaga H, Kiriike N, Iwasaki Y, Miyata A, Yamagami S, Kaye WH (1999). Clinical characteristics in patients with anorexia nervosa and obsessive-compulsive disorder. Psychol Med 29:407-414.
40. McCauley JL, Olson LM, Dowd M, Amin T, Steele A, Blakely RD, et al. (2004). Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive subset of autism. Am J Med Genet B Neuropsychiatr Genet 127:104-112.
41. McDougle CJ, Kresch LE, Goodman WK, Naylor ST, Volkmar FR, Cohen DJ, Price LH (1995). A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. Am J Psychiatry 152:772-777.
42. McDougle CJ, Epperson CN, Price LH, Gelernter J (1998). Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive-compulsive disorder. Mol Psychiatry 3:270-273.
43. McDougle CJ, Kresch LE, Posey DJ (2000). Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors. J Autism Dev Disord 30:427-435.
44. Micallef J, Blin O (2001). Neurobiology and clinical pharmacology of obsessive-compulsive disorder. Clin Neuropharmacol 24:191-207.
45. Mossner R, Walitza S, Geller F, Scherag A, Gutknecht L, Jacob C, et al. (2005). Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol 7:1-6.
46. Mulder EJ, Anderson GM, Kema IP, Brugman AM, Ketelaars CE, De Bildt A, et al. (2005). Serotonin transporter intron 2 polymorphism associated with rigid-compulsive behaviors in Dutch individuals with pervasive developmental disorder. Am J Med Genet B Neuropsychiatr Genet 133:93-96.
47. Mundo E, Richter MA, Zai G, Sam F, Mcbride J, Macciardi F, Kennedy JL (2002). 5HT1Dbeta receptor gene implicated in the pathogenesis of obsessive-compulsive disorder: further evidence from a family-based association study. Mol Psychiatry 7:805-809.
48. Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR (1989). Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder. Br J Psychiatry 155(Suppl 8):15-24.
49. Murphy DL, Lerner A, Rudnick G, Lesch KP (2004). Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol Interv 4:109-123.
50. Nestadt G, Samuels J, Riddle M, Bienvenu OJ III, Liang KY, Labuda M, et al. (2000). A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 57:358-363.
51. Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, et al. (2003). Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry 8:895, 933-936.
52. Pato MT, Pato CN, Pauls DL (2002). Recent findings in the genetics of OCD. J Clin Psychiatry 63(Suppl 6):30-33.
53. Pauls DL (1992). The genetics of obsessive compulsive disorder and Gilles de la Tourette's syndrome. Psychiatr Clin North Am 15:759-766.
54. Pauls DL, Alsobrook JP II, Goodman W, Rasmussen S, Leckman JF (1995). A family study of obsessive-compulsive disorder. Am J Psychiatry 152:76-84.
55. Prasad HC, Zhu CB, Mccauley JL, Samuvel DJ, Ramamoorthy S, Shelton RC, et al. (2005). Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci USA 102:11545-11550.
56. Risch N (1990). Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genet Epidemiol 7:3-16; discussion 17-45.
57. Ronaghi M, Karamohamed S, Pettersson B, Uhlen M, Nyren P (1996). Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 242:84-89.
58. Ronaghi M, Pettersson B, Uhlen M, Nyren P (1998a). PCR-introduced loop structure as primer in DNA sequencing. Biotechniques 25:876-878, 880-882, 884.
59. Ronaghi M, Uhlen M, Nyren P (1998b). A sequencing method based on real-time pyrophosphate. Science 281:363, 365.
60. Rudnick G (2006). Structure/function relationships in serotonin transporter: new insights from the structure of a bacterial transporter. Handb Exp Pharmacol 59-73.
61. Russell AJ, Mataix-Cols D, Anson M, Murphy DG (2005). Obsessions and compulsions in Asperger syndrome and high-functioning autism. Br J Psychiatry 186:525-528.
62. Sasson Y, Dekel S, Nacasch N, Chopra M, Zinger Y, Amital D, Zohar J (2005). Posttraumatic obsessive-compulsive disorder: a case series. Psychiatry Res 135:145-152.
63. Shih RA, Belmonte PL, Zandi PP (2004). A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry 16:260-283.
64. Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, et al. (2006). Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 11:763-770.
65. Slattery MJ, Dubbert BK, Allen AJ, Leonard HL, Swedo SE, Gourley MF (2004). Prevalence of obsessive-compulsive disorder in patients with systemic lupus erythematosus. J Clin Psychiatry 65:301-306.
66. Snider LA, Swedo SE (2004). PANDAS: current status and directions for research. Mol Psychiatry 9:900-907.
67. Sutcliffe JS, Delahanty RJ, Prasad HC, Mccauley JL, Han Q, Jiang L, et al. (2005). Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet 77:265-279.
68. Van Grootheest DS, Cath DC, Beekman AT, Boomsma DI (2005). Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet 8:450-458.
69. Walitza S, Wewetzer C, Warnke A, Gerlach M, Geller F, Gerber G, et al. (2002). 5-HT2A promoter polymorphism - 1438G/A in children and adolescents with obsessive-compulsive disorders. Mol Psychiatry 7:1054-1057.
70. Wendland JR, Martin BJ, Kruse MR, Lesch K-P, Murphy DL (2006). Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 11:224-226.
71. Wendland JR, Kruse MR, Cromer KC, Murphy DL (2007). A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder. Neuropsychopharmacology; Epub ahead of print.
72. --dependent neurotransmitter transporters. Nature 437:215-223.
73. Yonan AL, Alarcon M, Cheng R, Magnusson PK, Spence SJ, Palmer AA, et al. (2003). A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet 73:886-897.
74. Zai G, Bezchlibnyk YB, Richter MA, Arnold P, Burroughs E, Barr CL, Kennedy JL (2004). Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 129:64-68.
75. Zhang YW, Rudnick G (2005). Serotonin transporter mutations associated with obsessive-compulsive disorder and phosphorylation alter binding affinity for inhibitors. Neuropharmacology 49:791-797.
76. Zhang YW, Rudnick G (2006). The cytoplasmic substrate permeation pathway of serotonin transporter. J Biol Chem 281:36213-36220.